[ET Net News Agency, 30 November 2022] ALI HEALTH (00241) rose 4.59% to HK$6.38.
It hits an intra-day high of HK$6.41, and an intra-day low of HK$5.95. The total shares
traded was 98.08 million, with a value of HK$611.37m. The active buy/sell ratio is 55:45,
with net buying turnover of HK$55.75m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$21.48m, with volume weighted average price of HK$6.212.
CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of HK$14.88m, with
volume weighted average price of HK$6.25. The stock has risen a combined 14.75% over the
past 2 consecutive trading days.
The Hang Seng Index now rose 406 points, or 2.24% to 18,611; the Hang Seng China
Enterprises Index now rose 146 points, or 2.34% to 6,382; the Hang Seng TECH Index now
rose 108 points, or 2.93% to 3,804; with an overall turnover of HK$136.11b.
The SSE Composite Index now rose 1 point, or 0.05% to 3,151, with an overall turnover of
RMB404.5b.
The SZSE Component Index now rose 19 points, or 0.18% to 11,108, with an overall
turnover of RMB227.35b.
Basic Information
=================
----------------------------------
Nominal 6.380 % Chg +4.59%
High 6.410 Low 5.950
Shares Tr 98.08m Turnover 611.37m
10-D SMA 5.753 %H.V 89.423
20-D SMA 5.133 VWAP 6.234
50-D SMA 4.201 RSI14 75.408
----------------------------------
Status: Active buy/sell ratio is 55:45, with net buying turnover of HK$55.75m, rising a
combined 14.75% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ALI HEALTH (00241) 6.38 +4.59
SINOPHARM (01099) 18.50 +3.58
SINO BIOPHARM (01177) 4.57 +1.33
INNOVENT BIO (01801) 30.65 +2.00
JXR (01951) 6.08 -2.56
FOSUN PHARMA (02196) 25.50 Unchanged
WUXI BIO (02269) 49.95 +2.04
CANSINOBIO (06185) 101.90 -1.55
JD HEALTH (06618) 68.45 +3.71
AKESO-B (09926) 33.35 -0.30
---------------------------------------------
(ed)